Related Experiment Video
Updated: Dec 1, 2025

A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
Incidence of Refeeding Syndrome in Children With Failure to Thrive
Megan E Coe1, Lucinda Castellano2, Megan Elliott3
1Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia; megan.coe@nationwidechildrens.org.
Insights
Refeeding syndrome was not found in healthy children under 3 years old admitted for failure to thrive (FTT). Routine lab monitoring showed no electrolyte issues, suggesting current practices may be excessive.
Area of Science:
- Pediatrics
- Clinical Nutrition
- Internal Medicine
Background:
- Failure to thrive (FTT) is a common reason for hospitalization in children under 3 years old.
- Refeeding syndrome is a potential complication of nutritional rehabilitation in malnourished patients.
- Current guidelines for monitoring refeeding syndrome in FTT patients are not well-established.
Purpose of the Study:
- To determine the incidence of refeeding syndrome in otherwise healthy children under 3 years of age admitted for FTT.
- To evaluate the necessity of routine laboratory monitoring for electrolyte disturbances in this population.
Main Methods:
- A multicenter retrospective cohort study included 179 patients aged ≤36 months with a primary FTT diagnosis.
- Exclusion criteria included ICU admission, parenteral nutrition, prematurity, gastrostomy tube feeds, and complex chronic conditions.
- The primary outcome was laboratory evidence of refeeding syndrome; laboratory work was assessed at admission and post-admission.
Main Results:
- None of the 179 patients exhibited laboratory evidence of refeeding syndrome.
- 81% had admission lab work, and 39% had repeat lab work; 6% experienced adverse events from repeat draws.
- No significant electrolyte derangements indicative of refeeding syndrome were observed.
Conclusions:
- Routine laboratory monitoring for refeeding syndrome is not indicated in otherwise healthy, hospitalized children under 3 with FTT.
- Further research is needed to establish evidence-based guidelines for nutritional management and monitoring in this population.
- Reducing unnecessary laboratory evaluations can improve patient safety and reduce healthcare costs.
Objectives:
To determine the incidence of refeeding syndrome in otherwise healthy children <3 years of age admitted for failure to thrive (FTT).
Methods:
A multicenter retrospective cohort study was performed on patients aged ≤36 months admitted with a primary diagnosis of FTT from January 1, 2011, to December 31, 2016. The primary outcome measure was the percentage of patients with laboratory evidence of refeeding syndrome. Exclusion criteria included admission to an ICU, parenteral nutrition, history of prematurity, gastrostomy tube feeds, and any complex chronic conditions.
Results:
Of the 179 patients meeting inclusion criteria, none had laboratory evidence of refeeding syndrome. Of these, 145 (81%) had laboratory work done at the time of admission, and 69 (39%) had laboratory work repeated after admission. A small percentage (6%) of included patients experienced an adverse event due to repeat laboratory draw.
Conclusions:
In otherwise healthy hospitalized patients <3 years of age with a primary diagnosis of FTT, routine laboratory monitoring for electrolyte derangements did not reveal any cases of refeeding syndrome. More robust studies are needed to determine the safety and feasibility of applying low-risk guidelines to this patient population to reduce practice variability and eliminate unnecessary laboratory evaluation and monitoring.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Acute Kidney Injury III: Clinical Manifestations
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

